nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—ovarian cancer	0.0249	0.857	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—ABCB1—ovarian cancer	0.00415	0.143	CrCbGaD
Nitazoxanide—Malaise—Vinorelbine—ovarian cancer	0.00403	0.00415	CcSEcCtD
Nitazoxanide—Anorexia—Melphalan—ovarian cancer	0.00398	0.00409	CcSEcCtD
Nitazoxanide—Feeling abnormal—Chlorambucil—ovarian cancer	0.00394	0.00406	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00391	0.00403	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00388	0.004	CcSEcCtD
Nitazoxanide—Hypertension—Vinorelbine—ovarian cancer	0.00385	0.00397	CcSEcCtD
Nitazoxanide—Creatinine increased—Doxorubicin—ovarian cancer	0.00382	0.00393	CcSEcCtD
Nitazoxanide—Myalgia—Vinorelbine—ovarian cancer	0.0038	0.00391	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.0038	0.00391	CcSEcCtD
Nitazoxanide—Body temperature increased—Chlorambucil—ovarian cancer	0.00378	0.0039	CcSEcCtD
Nitazoxanide—Abdominal pain—Chlorambucil—ovarian cancer	0.00378	0.0039	CcSEcCtD
Nitazoxanide—Discomfort—Vinorelbine—ovarian cancer	0.00376	0.00387	CcSEcCtD
Nitazoxanide—Dyspepsia—Topotecan—ovarian cancer	0.00375	0.00386	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00373	0.00384	CcSEcCtD
Nitazoxanide—Decreased appetite—Topotecan—ovarian cancer	0.0037	0.00381	CcSEcCtD
Nitazoxanide—Dyspepsia—Melphalan—ovarian cancer	0.00367	0.00378	CcSEcCtD
Nitazoxanide—Pain—Topotecan—ovarian cancer	0.00364	0.00375	CcSEcCtD
Nitazoxanide—Constipation—Topotecan—ovarian cancer	0.00364	0.00375	CcSEcCtD
Nitazoxanide—Decreased appetite—Melphalan—ovarian cancer	0.00363	0.00373	CcSEcCtD
Nitazoxanide—Epistaxis—Paclitaxel—ovarian cancer	0.00362	0.00373	CcSEcCtD
Nitazoxanide—Infection—Vinorelbine—ovarian cancer	0.00362	0.00373	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Epirubicin—ovarian cancer	0.00361	0.00372	CcSEcCtD
Nitazoxanide—Pain—Melphalan—ovarian cancer	0.00357	0.00367	CcSEcCtD
Nitazoxanide—Tachycardia—Vinorelbine—ovarian cancer	0.00356	0.00366	CcSEcCtD
Nitazoxanide—Hypersensitivity—Chlorambucil—ovarian cancer	0.00353	0.00363	CcSEcCtD
Nitazoxanide—Feeling abnormal—Topotecan—ovarian cancer	0.00351	0.00362	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Topotecan—ovarian cancer	0.00348	0.00359	CcSEcCtD
Nitazoxanide—Anorexia—Vinorelbine—ovarian cancer	0.00347	0.00358	CcSEcCtD
Nitazoxanide—Rhinitis—Paclitaxel—ovarian cancer	0.00346	0.00356	CcSEcCtD
Nitazoxanide—Asthenia—Chlorambucil—ovarian cancer	0.00343	0.00354	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00343	0.00354	CcSEcCtD
Nitazoxanide—Pharyngitis—Paclitaxel—ovarian cancer	0.00342	0.00353	CcSEcCtD
Nitazoxanide—Pruritus—Chlorambucil—ovarian cancer	0.00339	0.00349	CcSEcCtD
Nitazoxanide—Abdominal pain—Topotecan—ovarian cancer	0.00337	0.00347	CcSEcCtD
Nitazoxanide—Body temperature increased—Topotecan—ovarian cancer	0.00337	0.00347	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.00334	0.00344	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00332	0.00342	CcSEcCtD
Nitazoxanide—Diarrhoea—Chlorambucil—ovarian cancer	0.00327	0.00337	CcSEcCtD
Nitazoxanide—Decreased appetite—Vinorelbine—ovarian cancer	0.00317	0.00326	CcSEcCtD
Nitazoxanide—Hypersensitivity—Topotecan—ovarian cancer	0.00314	0.00323	CcSEcCtD
Nitazoxanide—Pain—Vinorelbine—ovarian cancer	0.00312	0.00321	CcSEcCtD
Nitazoxanide—Constipation—Vinorelbine—ovarian cancer	0.00312	0.00321	CcSEcCtD
Nitazoxanide—Chills—Paclitaxel—ovarian cancer	0.0031	0.00319	CcSEcCtD
Nitazoxanide—Hypersensitivity—Melphalan—ovarian cancer	0.00307	0.00316	CcSEcCtD
Nitazoxanide—Epistaxis—Docetaxel—ovarian cancer	0.00307	0.00316	CcSEcCtD
Nitazoxanide—Asthenia—Topotecan—ovarian cancer	0.00306	0.00315	CcSEcCtD
Nitazoxanide—Vomiting—Chlorambucil—ovarian cancer	0.00304	0.00313	CcSEcCtD
Nitazoxanide—Increased appetite—Epirubicin—ovarian cancer	0.00303	0.00313	CcSEcCtD
Nitazoxanide—Pruritus—Topotecan—ovarian cancer	0.00301	0.0031	CcSEcCtD
Nitazoxanide—Feeling abnormal—Vinorelbine—ovarian cancer	0.003	0.00309	CcSEcCtD
Nitazoxanide—Asthenia—Melphalan—ovarian cancer	0.00299	0.00308	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00298	0.00307	CcSEcCtD
Nitazoxanide—Flatulence—Paclitaxel—ovarian cancer	0.00296	0.00305	CcSEcCtD
Nitazoxanide—Pruritus—Melphalan—ovarian cancer	0.00295	0.00304	CcSEcCtD
Nitazoxanide—Rhinitis—Docetaxel—ovarian cancer	0.00293	0.00302	CcSEcCtD
Nitazoxanide—Diarrhoea—Topotecan—ovarian cancer	0.00291	0.003	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Docetaxel—ovarian cancer	0.00291	0.003	CcSEcCtD
Nitazoxanide—Back pain—Paclitaxel—ovarian cancer	0.0029	0.00299	CcSEcCtD
Nitazoxanide—Pharyngitis—Docetaxel—ovarian cancer	0.0029	0.00299	CcSEcCtD
Nitazoxanide—Muscle spasms—Paclitaxel—ovarian cancer	0.00289	0.00297	CcSEcCtD
Nitazoxanide—Abdominal pain—Vinorelbine—ovarian cancer	0.00288	0.00297	CcSEcCtD
Nitazoxanide—Body temperature increased—Vinorelbine—ovarian cancer	0.00288	0.00297	CcSEcCtD
Nitazoxanide—Diarrhoea—Melphalan—ovarian cancer	0.00285	0.00294	CcSEcCtD
Nitazoxanide—Nausea—Chlorambucil—ovarian cancer	0.00284	0.00293	CcSEcCtD
Nitazoxanide—Dizziness—Topotecan—ovarian cancer	0.00282	0.0029	CcSEcCtD
Nitazoxanide—Tremor—Paclitaxel—ovarian cancer	0.00281	0.0029	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—ovarian cancer	0.00281	0.00289	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00279	0.00287	CcSEcCtD
Nitazoxanide—Anaemia—Paclitaxel—ovarian cancer	0.00278	0.00286	CcSEcCtD
Nitazoxanide—Vomiting—Topotecan—ovarian cancer	0.00271	0.00279	CcSEcCtD
Nitazoxanide—Malaise—Paclitaxel—ovarian cancer	0.00271	0.00279	CcSEcCtD
Nitazoxanide—Syncope—Paclitaxel—ovarian cancer	0.00269	0.00277	CcSEcCtD
Nitazoxanide—Rash—Topotecan—ovarian cancer	0.00269	0.00277	CcSEcCtD
Nitazoxanide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00268	0.00276	CcSEcCtD
Nitazoxanide—Dermatitis—Topotecan—ovarian cancer	0.00268	0.00276	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Epirubicin—ovarian cancer	0.00267	0.00275	CcSEcCtD
Nitazoxanide—Headache—Topotecan—ovarian cancer	0.00267	0.00275	CcSEcCtD
Nitazoxanide—Vomiting—Melphalan—ovarian cancer	0.00265	0.00273	CcSEcCtD
Nitazoxanide—Loss of consciousness—Paclitaxel—ovarian cancer	0.00264	0.00272	CcSEcCtD
Nitazoxanide—Rash—Melphalan—ovarian cancer	0.00263	0.00271	CcSEcCtD
Nitazoxanide—Dermatitis—Melphalan—ovarian cancer	0.00263	0.00271	CcSEcCtD
Nitazoxanide—Chills—Docetaxel—ovarian cancer	0.00262	0.0027	CcSEcCtD
Nitazoxanide—Asthenia—Vinorelbine—ovarian cancer	0.00261	0.00269	CcSEcCtD
Nitazoxanide—Hypertension—Paclitaxel—ovarian cancer	0.00259	0.00267	CcSEcCtD
Nitazoxanide—Pruritus—Vinorelbine—ovarian cancer	0.00258	0.00266	CcSEcCtD
Nitazoxanide—Myalgia—Paclitaxel—ovarian cancer	0.00256	0.00263	CcSEcCtD
Nitazoxanide—Nausea—Topotecan—ovarian cancer	0.00253	0.00261	CcSEcCtD
Nitazoxanide—Discomfort—Paclitaxel—ovarian cancer	0.00253	0.0026	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00251	0.00259	CcSEcCtD
Nitazoxanide—Dry mouth—Paclitaxel—ovarian cancer	0.0025	0.00258	CcSEcCtD
Nitazoxanide—Diarrhoea—Vinorelbine—ovarian cancer	0.00249	0.00257	CcSEcCtD
Nitazoxanide—Nausea—Melphalan—ovarian cancer	0.00248	0.00255	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00247	0.00255	CcSEcCtD
Nitazoxanide—Influenza—Epirubicin—ovarian cancer	0.00246	0.00254	CcSEcCtD
Nitazoxanide—Back pain—Docetaxel—ovarian cancer	0.00246	0.00254	CcSEcCtD
Nitazoxanide—Oedema—Paclitaxel—ovarian cancer	0.00245	0.00252	CcSEcCtD
Nitazoxanide—Muscle spasms—Docetaxel—ovarian cancer	0.00245	0.00252	CcSEcCtD
Nitazoxanide—Infection—Paclitaxel—ovarian cancer	0.00243	0.00251	CcSEcCtD
Nitazoxanide—Shock—Paclitaxel—ovarian cancer	0.00241	0.00248	CcSEcCtD
Nitazoxanide—Dizziness—Vinorelbine—ovarian cancer	0.00241	0.00248	CcSEcCtD
Nitazoxanide—Tachycardia—Paclitaxel—ovarian cancer	0.00239	0.00246	CcSEcCtD
Nitazoxanide—Anaemia—Docetaxel—ovarian cancer	0.00235	0.00242	CcSEcCtD
Nitazoxanide—Anorexia—Paclitaxel—ovarian cancer	0.00234	0.00241	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.00233	0.0024	CcSEcCtD
Nitazoxanide—Vomiting—Vinorelbine—ovarian cancer	0.00232	0.00239	CcSEcCtD
Nitazoxanide—Dysuria—Epirubicin—ovarian cancer	0.0023	0.00237	CcSEcCtD
Nitazoxanide—Rash—Vinorelbine—ovarian cancer	0.0023	0.00237	CcSEcCtD
Nitazoxanide—Dermatitis—Vinorelbine—ovarian cancer	0.0023	0.00236	CcSEcCtD
Nitazoxanide—Headache—Vinorelbine—ovarian cancer	0.00228	0.00235	CcSEcCtD
Nitazoxanide—Syncope—Docetaxel—ovarian cancer	0.00228	0.00235	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—ovarian cancer	0.00228	0.00235	CcSEcCtD
Nitazoxanide—Loss of consciousness—Docetaxel—ovarian cancer	0.00224	0.0023	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00223	0.0023	CcSEcCtD
Nitazoxanide—Insomnia—Paclitaxel—ovarian cancer	0.00222	0.00228	CcSEcCtD
Nitazoxanide—Hypertension—Docetaxel—ovarian cancer	0.0022	0.00226	CcSEcCtD
Nitazoxanide—Somnolence—Paclitaxel—ovarian cancer	0.00218	0.00224	CcSEcCtD
Nitazoxanide—Myalgia—Docetaxel—ovarian cancer	0.00217	0.00223	CcSEcCtD
Nitazoxanide—Nausea—Vinorelbine—ovarian cancer	0.00216	0.00223	CcSEcCtD
Nitazoxanide—Dyspepsia—Paclitaxel—ovarian cancer	0.00216	0.00222	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—ovarian cancer	0.00213	0.0022	CcSEcCtD
Nitazoxanide—Decreased appetite—Paclitaxel—ovarian cancer	0.00213	0.00219	CcSEcCtD
Nitazoxanide—Dry mouth—Docetaxel—ovarian cancer	0.00212	0.00218	CcSEcCtD
Nitazoxanide—Pain—Paclitaxel—ovarian cancer	0.0021	0.00216	CcSEcCtD
Nitazoxanide—Constipation—Paclitaxel—ovarian cancer	0.0021	0.00216	CcSEcCtD
Nitazoxanide—Oedema—Docetaxel—ovarian cancer	0.00208	0.00214	CcSEcCtD
Nitazoxanide—Epistaxis—Epirubicin—ovarian cancer	0.00207	0.00213	CcSEcCtD
Nitazoxanide—Infection—Docetaxel—ovarian cancer	0.00206	0.00213	CcSEcCtD
Nitazoxanide—Shock—Docetaxel—ovarian cancer	0.00204	0.00211	CcSEcCtD
Nitazoxanide—Tachycardia—Docetaxel—ovarian cancer	0.00203	0.00209	CcSEcCtD
Nitazoxanide—Feeling abnormal—Paclitaxel—ovarian cancer	0.00202	0.00208	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.002	0.00206	CcSEcCtD
Nitazoxanide—Anorexia—Docetaxel—ovarian cancer	0.00198	0.00204	CcSEcCtD
Nitazoxanide—Rhinitis—Epirubicin—ovarian cancer	0.00198	0.00204	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Epirubicin—ovarian cancer	0.00196	0.00202	CcSEcCtD
Nitazoxanide—Pharyngitis—Epirubicin—ovarian cancer	0.00196	0.00202	CcSEcCtD
Nitazoxanide—Body temperature increased—Paclitaxel—ovarian cancer	0.00194	0.002	CcSEcCtD
Nitazoxanide—Abdominal pain—Paclitaxel—ovarian cancer	0.00194	0.002	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—ovarian cancer	0.00192	0.00197	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00189	0.00195	CcSEcCtD
Nitazoxanide—Insomnia—Docetaxel—ovarian cancer	0.00188	0.00194	CcSEcCtD
Nitazoxanide—Somnolence—Docetaxel—ovarian cancer	0.00185	0.0019	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—ovarian cancer	0.00183	0.00188	CcSEcCtD
Nitazoxanide—Dyspepsia—Docetaxel—ovarian cancer	0.00183	0.00188	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00182	0.00187	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—ovarian cancer	0.00181	0.00187	CcSEcCtD
Nitazoxanide—Decreased appetite—Docetaxel—ovarian cancer	0.00181	0.00186	CcSEcCtD
Nitazoxanide—Hypersensitivity—Paclitaxel—ovarian cancer	0.00181	0.00186	CcSEcCtD
Nitazoxanide—Pain—Docetaxel—ovarian cancer	0.00178	0.00183	CcSEcCtD
Nitazoxanide—Constipation—Docetaxel—ovarian cancer	0.00178	0.00183	CcSEcCtD
Nitazoxanide—Chills—Epirubicin—ovarian cancer	0.00177	0.00182	CcSEcCtD
Nitazoxanide—Asthenia—Paclitaxel—ovarian cancer	0.00176	0.00181	CcSEcCtD
Nitazoxanide—Pruritus—Paclitaxel—ovarian cancer	0.00173	0.00179	CcSEcCtD
Nitazoxanide—Feeling abnormal—Docetaxel—ovarian cancer	0.00171	0.00176	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.0017	0.00175	CcSEcCtD
Nitazoxanide—Flatulence—Epirubicin—ovarian cancer	0.00169	0.00174	CcSEcCtD
Nitazoxanide—Diarrhoea—Paclitaxel—ovarian cancer	0.00168	0.00173	CcSEcCtD
Nitazoxanide—Back pain—Epirubicin—ovarian cancer	0.00166	0.00171	CcSEcCtD
Nitazoxanide—Muscle spasms—Epirubicin—ovarian cancer	0.00165	0.0017	CcSEcCtD
Nitazoxanide—Abdominal pain—Docetaxel—ovarian cancer	0.00164	0.00169	CcSEcCtD
Nitazoxanide—Body temperature increased—Docetaxel—ovarian cancer	0.00164	0.00169	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—ovarian cancer	0.00164	0.00169	CcSEcCtD
Nitazoxanide—Dizziness—Paclitaxel—ovarian cancer	0.00162	0.00167	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Epirubicin—ovarian cancer	0.00159	0.00164	CcSEcCtD
Nitazoxanide—Anaemia—Epirubicin—ovarian cancer	0.00159	0.00163	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—ovarian cancer	0.00157	0.00161	CcSEcCtD
Nitazoxanide—Vomiting—Paclitaxel—ovarian cancer	0.00156	0.0016	CcSEcCtD
Nitazoxanide—Malaise—Epirubicin—ovarian cancer	0.00155	0.00159	CcSEcCtD
Nitazoxanide—Rash—Paclitaxel—ovarian cancer	0.00155	0.00159	CcSEcCtD
Nitazoxanide—Dermatitis—Paclitaxel—ovarian cancer	0.00154	0.00159	CcSEcCtD
Nitazoxanide—Syncope—Epirubicin—ovarian cancer	0.00154	0.00159	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—ovarian cancer	0.00154	0.00158	CcSEcCtD
Nitazoxanide—Headache—Paclitaxel—ovarian cancer	0.00154	0.00158	CcSEcCtD
Nitazoxanide—Hypersensitivity—Docetaxel—ovarian cancer	0.00153	0.00158	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—ovarian cancer	0.00153	0.00157	CcSEcCtD
Nitazoxanide—Loss of consciousness—Epirubicin—ovarian cancer	0.00151	0.00155	CcSEcCtD
Nitazoxanide—Asthenia—Docetaxel—ovarian cancer	0.00149	0.00154	CcSEcCtD
Nitazoxanide—Hypertension—Epirubicin—ovarian cancer	0.00148	0.00153	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00147	0.00152	CcSEcCtD
Nitazoxanide—Pruritus—Docetaxel—ovarian cancer	0.00147	0.00151	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—ovarian cancer	0.00147	0.00151	CcSEcCtD
Nitazoxanide—Myalgia—Epirubicin—ovarian cancer	0.00146	0.00151	CcSEcCtD
Nitazoxanide—Nausea—Paclitaxel—ovarian cancer	0.00146	0.0015	CcSEcCtD
Nitazoxanide—Discomfort—Epirubicin—ovarian cancer	0.00144	0.00149	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—ovarian cancer	0.00143	0.00148	CcSEcCtD
Nitazoxanide—Dry mouth—Epirubicin—ovarian cancer	0.00143	0.00147	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—ovarian cancer	0.00142	0.00147	CcSEcCtD
Nitazoxanide—Diarrhoea—Docetaxel—ovarian cancer	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Oedema—Epirubicin—ovarian cancer	0.0014	0.00144	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—ovarian cancer	0.0014	0.00144	CcSEcCtD
Nitazoxanide—Infection—Epirubicin—ovarian cancer	0.00139	0.00143	CcSEcCtD
Nitazoxanide—Shock—Epirubicin—ovarian cancer	0.00138	0.00142	CcSEcCtD
Nitazoxanide—Dizziness—Docetaxel—ovarian cancer	0.00137	0.00141	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—ovarian cancer	0.00137	0.00141	CcSEcCtD
Nitazoxanide—Tachycardia—Epirubicin—ovarian cancer	0.00137	0.00141	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—ovarian cancer	0.00135	0.00139	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—ovarian cancer	0.00134	0.00138	CcSEcCtD
Nitazoxanide—Anorexia—Epirubicin—ovarian cancer	0.00134	0.00138	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—ovarian cancer	0.00132	0.00136	CcSEcCtD
Nitazoxanide—Vomiting—Docetaxel—ovarian cancer	0.00132	0.00136	CcSEcCtD
Nitazoxanide—Rash—Docetaxel—ovarian cancer	0.00131	0.00135	CcSEcCtD
Nitazoxanide—Dermatitis—Docetaxel—ovarian cancer	0.00131	0.00135	CcSEcCtD
Nitazoxanide—Headache—Docetaxel—ovarian cancer	0.0013	0.00134	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—ovarian cancer	0.0013	0.00134	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—ovarian cancer	0.00129	0.00133	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00128	0.00131	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—ovarian cancer	0.00128	0.00131	CcSEcCtD
Nitazoxanide—Insomnia—Epirubicin—ovarian cancer	0.00127	0.00131	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—ovarian cancer	0.00127	0.0013	CcSEcCtD
Nitazoxanide—Somnolence—Epirubicin—ovarian cancer	0.00125	0.00128	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—ovarian cancer	0.00124	0.00127	CcSEcCtD
Nitazoxanide—Nausea—Docetaxel—ovarian cancer	0.00123	0.00127	CcSEcCtD
Nitazoxanide—Dyspepsia—Epirubicin—ovarian cancer	0.00123	0.00127	CcSEcCtD
Nitazoxanide—Decreased appetite—Epirubicin—ovarian cancer	0.00122	0.00125	CcSEcCtD
Nitazoxanide—Constipation—Epirubicin—ovarian cancer	0.0012	0.00123	CcSEcCtD
Nitazoxanide—Pain—Epirubicin—ovarian cancer	0.0012	0.00123	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00118	0.00122	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—ovarian cancer	0.00117	0.00121	CcSEcCtD
Nitazoxanide—Feeling abnormal—Epirubicin—ovarian cancer	0.00115	0.00119	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—ovarian cancer	0.00115	0.00119	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00115	0.00118	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—ovarian cancer	0.00114	0.00118	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—ovarian cancer	0.00113	0.00116	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—ovarian cancer	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—ovarian cancer	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Body temperature increased—Epirubicin—ovarian cancer	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Abdominal pain—Epirubicin—ovarian cancer	0.00111	0.00114	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—ovarian cancer	0.00107	0.0011	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00106	0.00109	CcSEcCtD
Nitazoxanide—Hypersensitivity—Epirubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—ovarian cancer	0.00102	0.00106	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—ovarian cancer	0.00102	0.00106	CcSEcCtD
Nitazoxanide—Asthenia—Epirubicin—ovarian cancer	0.00101	0.00104	CcSEcCtD
Nitazoxanide—Pruritus—Epirubicin—ovarian cancer	0.000991	0.00102	CcSEcCtD
Nitazoxanide—Diarrhoea—Epirubicin—ovarian cancer	0.000959	0.000987	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000955	0.000984	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—ovarian cancer	0.00093	0.000958	CcSEcCtD
Nitazoxanide—Dizziness—Epirubicin—ovarian cancer	0.000927	0.000954	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—ovarian cancer	0.000917	0.000945	CcSEcCtD
Nitazoxanide—Vomiting—Epirubicin—ovarian cancer	0.000891	0.000918	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—ovarian cancer	0.000887	0.000914	CcSEcCtD
Nitazoxanide—Rash—Epirubicin—ovarian cancer	0.000883	0.00091	CcSEcCtD
Nitazoxanide—Dermatitis—Epirubicin—ovarian cancer	0.000883	0.000909	CcSEcCtD
Nitazoxanide—Headache—Epirubicin—ovarian cancer	0.000878	0.000904	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—ovarian cancer	0.000857	0.000883	CcSEcCtD
Nitazoxanide—Nausea—Epirubicin—ovarian cancer	0.000832	0.000857	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—ovarian cancer	0.000824	0.000849	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—ovarian cancer	0.000817	0.000842	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—ovarian cancer	0.000817	0.000841	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—ovarian cancer	0.000812	0.000837	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—ovarian cancer	0.00077	0.000793	CcSEcCtD
